Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 10 results for "orchid pharma"

Orchid Pharma zooms 20% as Tamil Nadu API facility gets EIR report from USFDA
Money Control

ITI, Orchid Pharma zoom over 35% in two days in weak market

ITI and Orchid Pharma were up 19% and 16%, respectively, extending their Thursday's 20% rally on NSE. Last Updated at September 22, 2017 12:26 IST Business Standard, 1 month ago

4 images for orchid pharma

Money Control, 1 month ago
Money Control, 2 months ago
Money Control, 6 months ago
Money Control, 6 months ago

JP Associates, Videocon recover from Monday's fall; Nagarjuna Oil dips 10%

Meanwhile, Jai Balaji, Orchid Pharma, Unity Infra and Nagarjuna Oil, extended losses
 Business Standard1 month ago

NCLT orders initiating insolvency proceedings against Orchid Pharma

id Pharma may appeal against the insolvency proceedings initiated against it August 23, 2017 Last Updated at 10:18 IST
 Business Standard2 months ago NCLT initiates insolvency proceedings against Orchid Pharma  Business Standard2 months ago

Sensex Pares Gains; Telecom Stocks Rally

Posted by Equitymaster After opening the day on a firm note, the Indian share markets �pared its morning gains to trade flat. Sectoral indices are trading mixed, with stocks in the� realty sector �& information technology sector leading the pack of ...
 Equitymaster.com1 day ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less